Obstetrics & Gynecology Science

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer

Roshni D. Kalachand, Ciaran O’Riain, Sinead Toomey, Aoife Carr, Kirsten M. Timms, Sharon O’Toole, Stephen Madden, Mark Bates, John J. O’Leary, Noreen Gleeson, Dearbhaile O’Donnell, Liam Grogan, Oscar Breathnach, Angela Farrelly, Britta Stordal, Bryan T. Hennessy

Obstet Gynecol Sci. 2020;63(5):643-654. Published online September 2, 2020
DOI: https://doi.org/10.5468/ogs.20033

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer

Obstetrics & Gynecology Science. 2020;63(5):643-654

Link1

Link2 Link3

Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history

Patricia N Tonin, Anne-Marie Mes-Masson, Steven A Narod, Parviz Ghadirian, Diane Provencher

Clinical Genetics. 1999;55(5):318-324

Link1 Link2 Link3

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Greece

Chrissovaladis Koumpis, Constantine Dimitrakakis, Aris Antsaklis, Robert Royer, Shiyu Zhang, Steven A Narod, Joanne Kotsopoulos

Hereditary Cancer in Clinical Practice. 2011;9(1):

Link1

Link2 Link3 Link4

Prevalence ofBRCA1andBRCA2mutations in unselected breast cancer patients from Peru

J. Abugattas, M. Llacuachaqui, Y. Sullcahuaman Allende, A. Arias Velásquez, R. Velarde, J. Cotrina, M. Garcés, M. León, G. Calderón, M. de la Cruz, P. Mora, R. Royer, J. Herzog, J.N. Weitzel, S.A. Narod

Clinical Genetics. 2014;88(4):371-375

Link1

Prevalence of BRCA1 and BRCA2 pathogenic sequence variants in ovarian cancer patients in the Gulf region: the PREDICT study

Fathi Azribi, Ehab Abdou, Emad Dawoud, Mohamed Ashour, Amgad Kamal, Mohamed Al Sayed, Ikram Burney

BMC Cancer. 2021;21(1):

Link1

Link2 Link3

Prevalence and clinical correlations of BRCA1/BRCA2 unclassified variant carriers among unselected primary ovarian cancer cases – preliminary report

Ewa J. Majdak, Geertruida H. De Bock, Izabela Brozek, Magdalena Perkowska, Karolina Ochman, Jaroslaw Debniak, Tomasz Milczek, Cees J. Cornelisse, J. Jassem, Janusz Emerich, Janusz Limon, Peter Devilee

European Journal of Cancer. 2005;41(1):143-150

Link1 Link2

Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer

PO Chappuis, N Hamel, A-J Paradis, J Deschênes, A Robidoux, C Potvin, J Cantin, P Tonin, P Ghadirian, WD Foulkes

Clinical Genetics. 2001;59(6):418-423

Link1 Link2 Link3

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Medellín, Colombia

Julián Esteban Londoño Hernández, Marcia Llacuachaqui, Gonzalo Vásquez Palacio, Juan David Figueroa, Jorge Madrid, Mauricio Lema, Robert Royer, Song Li, Garrett Larson, Jeffrey N Weitzel, Steven A Narod

Hereditary Cancer in Clinical Practice. 2014;12(1):

Link1

Link2 Link3 Link4

Hereditary Risk of Breast and Ovarian Cancer: BRCA1 and BRCA2

Thomas S. Frank

Encyclopedia of Cancer. 2002;381-385

Link1 Link2

Estimating survival rates after ovarian cancer among women tested for BRCA1 and BRCA2 mutations

SA Narod, JRK Moody, B Rosen, I Fan, A Risch, P Sun, JR McLaughlin

Clinical Genetics. 2013;83(3):232-237

Link1 Link2